Preparation and assessment of chitosan-coated superparamagnetic Fe 3O4 nanoparticles for controlled delivery of methotrexate

Research in Pharmaceutical Sciences

Volumn 8, Issue 1, 2013, Pages 25-33

  Mohammadi Samani, S ^a   Miri, R ^a,b   Salmanpour, M ^a   Khalighian, N ^b   Sotoudeh, S ^a   Erfani, N ^c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chitosan; Fe3O4; Magnetic targeting drug delivery; Methotrexate; Nanoparticles; Superparamagnetic

Indexed keywords

CHITOSAN; MAGNETITE NANOPARTICLE; METHOTREXATE;

ARTICLE; CONTROLLED DRUG RELEASE; CRYSTAL STRUCTURE; CYTOTOXICITY; DRUG COATING; DRUG FORMULATION; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; MAGNETIC FIELD; MAGNETOMETRY; PARTICLE SIZE; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 84873328737     PISSN: 17355362     EISSN: 17359414     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Lacy CF, Armstrong LL, Goldman MP, Lance LL. Drug Information Handbook. 18 ed: Lexi-Comp; 2010.
2. Lee SW, Kim JH, Park MC, Park YB, Chae WJ, Morio T, et al. Alleviation of rheumatoid arthritis by cell-transducible methotrexate upon transcutaneous delivery. Biomaterials. 2012;33:1563-1572.
3. Moura JA, Valduga CJ, Tavares ER, Kretzer IF, Maria DA, Maranhao RC. Novel formulation of a methotrexate derivative with a lipid nanoemulsion. Int J Nanomedicine. 2011;6:2285-2295.
4. Visser K, van der Heijde DM. Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature. Clin Exp Rheumatol. 2009;27:1017-1025.
5. Neves C, Jorge R, Barcelos A. The network of methotrexate toxicity. Acta Reumatol Port. 2009;34:11-34.
6. Benedek TG. Methotrexate: from its introduction to non-oncologic therapeutics to anti-TNF-alpha. Clin Exp Rheumatol. 2010;28:S3-8.
7. Taheri A, Dinarvand R, Nouri FS, Khorramizadeh MR, Borougeni AT, Mansoori P, et al. Use of biotin targeted methotrexate-human serum albumin conjugated nanoparticles to enhance methotrexate antitumor efficacy. Int J Nanomedicine. 2011;6:1863-1874.
8. Yousefi G, Foroutan SM, Zarghi A, Shafaati A. Synthesis and characterization of methotrexate polyethylene glycol esters as a drug delivery system. Chem Pharm Bull (Tokyo). 2010;58:147-153.
9. Paliwal R, Rai S, Vyas SP. Lipid drug conjugate (LDC) nanoparticles as autolymphotrophs for oral delivery of methotrexate. J Biomed Nanotechnol. 2011;7:130-131.
10. Hu J, Su Y, Zhang H, Xu T, Cheng Y. Design of interior-functionalized fully acetylated dendrimers for anticancer drug delivery. Biomaterials. 2011;32:9950-9959.
11. Li G, Jiang Y, Huang K, Ding P, Chen J. Preparation and properties of magnetic Fe3O4-chitosan nanoparticles. Journal of Alloys and Compounds. 2008;466:451-456.
12. Jain TK, Morales MA, Sahoo SK, Leslie-Pelecky DL, Labhasetwar V. Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol Pharm. 2005;2:194-205. (Pubitemid 40917416)
13. Li GY, Jiang YR, Huang KL, Ding P, Yao LL. Kinetics of adsorption of Saccharomyces cerevisiae mandelated dehydrogenase on magnetic Fe3O4- chitosan nanoparticles. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2008;320:11-18.
14. Bautista-Banosa S, Hernandez-Lauzardoa AN, Vallea MGV-d, Hernandez-Lopeza M, Barkab EA, Bosquez-Molinac E, et al. Chitosan as a potential natural compound to control pre and postharvest diseases of horticultural commodities. Crop Protection. 2006;25:108-118.
15. Hamidi M, Rafiei P, Azadi A, Mohammadi-Samani S. Encapsulation of valproate-loaded hydrogel nanoparticles in intact human erythrocytes: a novel nano-cell composite for drug delivery. J Pharm Sci. 2011;100:1702-1711.
16. Danesh-Bahreini MA, Shokri J, Samiei A, Kamali- Sarvestani E, Barzegar-Jalali M, Mohammadi- Samani S. Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c mice. Int J Nanomedicine. 2011;6:835-842.
17. Wu P, He X, Wang K, Tan W, He C, Zheng M. A novel methotrexate delivery system based on chitosan-methotrexate covalently conjugated nanoparticles. J Biomed Nanotechnol. 2009;5:557- 564.
18. Trapani A, Denora N, Iacobellis G, Sitterberg J, Bakowsky U, Kissel T. Methotrexate-loaded chitosan- and glycolchitosan-based nanoparticles: a promising strategy for the administration of the anticancer drug to brain tumors. AAPS Pharm Sci Tech. 2011;12:1302-1311.
19. Zhu A, Yuan L, Liao T. Suspension of Fe3O4 nanoparticles stabilized by chitosan and ocarboxymethylchitosan. Int J Pharm. 2008;350:361- 368.
20. Zhang X, Chen F, Ni J. A novel method to prepare magnetite chitosan microspheres conjugated with methotrexate (MTX) for the controlled release of MTX as a magnetic targeting drug delivery system. Drug Deliv. 2009;16:280-288.